APA

0.28%

$7.23 apa group

Well waht do I know! APA tanks on good numbers and HVN rallies...

First 17 Last

Share
Profile

Follow
swaggytrader

1,539 Posts.

191

29/02/24

10:51

Post #: 72665004
Share

Originally posted by Winniethepoo: ↑

I am no longer short but I think it is too early to go long as risks still look weighed to downside. Some of the reasons to hold back are:

1. Most basic issue is that free cash per share is the clearest indicator of value for this stock and it is going backwards by about -4.5% in this half (after adjusting for timing issues in prior period). The dividend is based on free cash flow so if free cash goes backwards so might the dividend.
2. Volumes are being forced down over time due to various policies e.g. banning new connections in Victoria. As volumes decrease so will future revenue.
3. Debt could be an issue and credit metrics are weakening. APA has started to issue hybrid debt at an eye watering 9.3% (when converted to AUD). It seems like future debt issuance might include more hybrids and there is another $2bn or so to refinance in next 12 months so real risk of a jump in interest costs.
4. Quality of revenue has decreased. Contracts lengths are getting shorter which gives less visibility on revenue. The company has stopped disclosing average contract length remaining which is a red flag.
5. Expenses are increasing faster than revenues due to new hires for "increased capability" and higher technology spending. In 4 years revenue has grown close to 20% while EBITDA has only grown about 10%.
6. Maintenance capex has ballooned and is another drag on cash to shareholders and reducing free cash flow available to shareholders. The total of stay in business capex and "foundational capex" expected in FY24 is $350m ($200m+$150m). In FY22 this total was just $165m.
7. Company indicating that cash tax will be a headwind. There was a benefit in last few years from COVID era related accelerated write offs which lowered cash tax. With this ending the cash tax will increase and free cash for shareholders will decrease.

Expand

Well waht do I know! APA tanks on good numbers and HVN rallies on a horrible result

APA Price at posting: $7.85 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

As Nvidia cools, we're looking to Aussie AI

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

There are more pages in this discussion • 9 more messages in this thread...

First 17 Last

Add APA (ASX) to my watchlist

(20min delay)
Last $7.23		Change 0.020(0.28%)		Mkt cap ! $9.278B

Open	High	Low	Value	Volume
$7.21	$7.34	$7.21	$17.98M	2.478M

Buyers (Bids)

No.	Vol.	Price($)
7	30037	$7.23

Sellers (Offers)

Price($)	Vol.	No.
$7.29	19132	3

View Market Depth

No.	Vol.	Price($)
7	30037	7.230
10	48624	7.220
14	21366	7.210
35	75068	7.200
4	1411	7.190

Price($)	Vol.	No.
7.290	19132	3
7.300	32691	2
7.310	23002	3
7.320	4265	1
7.330	3410	1

Last trade - 16.10pm 06/09/2024 (20 minute delay)

APA (ASX) Chart

Well waht do I know! APA tanks on good numbers and HVN rallies...

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Shekel Brainweigh investor presentation webinar – the future of retail automation

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

As Nvidia cools, we're looking to Aussie AI

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well waht do I know! APA tanks on good numbers and HVN rallies...

Top Stories

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Shekel Brainweigh investor presentation webinar – the future of retail automation

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

CBA breaks trading record on strong day for Aussie financials

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

As Nvidia cools, we're looking to Aussie AI

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News